These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 22809800

  • 1. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study.
    Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito J, Shuster JJ, Olfson M.
    BMJ; 2012 Jul 18; 345():e4627. PubMed ID: 22809800
    [Abstract] [Full Text] [Related]

  • 2. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.
    Pediatrics; 2007 Dec 18; 120(6):e1494-501. PubMed ID: 18055666
    [Abstract] [Full Text] [Related]

  • 3. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.
    Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC.
    J Am Acad Child Adolesc Psychiatry; 2012 Feb 18; 51(2):147-56. PubMed ID: 22265361
    [Abstract] [Full Text] [Related]

  • 4. Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.
    Bali V, Kamble PS, Aparasu RR.
    J Manag Care Spec Pharm; 2015 Jun 18; 21(6):486-98. PubMed ID: 26011550
    [Abstract] [Full Text] [Related]

  • 5. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
    Bange F, Le Heuzey MF, Acquaviva E, Delorme R, Mouren MC.
    Arch Pediatr; 2014 Jan 18; 21(1):108-12. PubMed ID: 24309201
    [Abstract] [Full Text] [Related]

  • 6. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR, Kamble PS, Chen H, Aparasu RR.
    J Child Adolesc Psychopharmacol; 2012 Apr 18; 22(2):139-48. PubMed ID: 22364400
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.
    Dalsgaard S, Kvist AP, Leckman JF, Nielsen HS, Simonsen M.
    J Child Adolesc Psychopharmacol; 2014 Aug 18; 24(6):302-10. PubMed ID: 24956171
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular safety of stimulants in children: findings from recent population-based cohort studies.
    Winterstein AG.
    Curr Psychiatry Rep; 2013 Aug 18; 15(8):379. PubMed ID: 23913135
    [Abstract] [Full Text] [Related]

  • 9. Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder.
    Houghton R, de Vries F, Loss G.
    CNS Drugs; 2020 Jan 18; 34(1):93-101. PubMed ID: 31768949
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid.
    Davis DW, Feygin Y, Creel L, Williams PG, Lohr WD, Jones VF, Le J, Pasquenza N, Ghosal S, Jawad K, Yan X, Liu G, McKinley S.
    J Pediatr; 2019 Apr 18; 207():185-191.e1. PubMed ID: 30545564
    [Abstract] [Full Text] [Related]

  • 11. Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.
    Winterstein AG, Gerhard T, Shuster J, Saidi A.
    Pediatrics; 2009 Jul 18; 124(1):e75-80. PubMed ID: 19564272
    [Abstract] [Full Text] [Related]

  • 12. Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.
    Westover AN, Halm EA.
    BMC Cardiovasc Disord; 2012 Jun 09; 12():41. PubMed ID: 22682429
    [Abstract] [Full Text] [Related]

  • 13. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.
    Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV.
    JAMA; 2011 Dec 28; 306(24):2673-83. PubMed ID: 22161946
    [Abstract] [Full Text] [Related]

  • 14. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.
    Martinez-Raga J, Knecht C, Szerman N, Martinez MI.
    CNS Drugs; 2013 Jan 28; 27(1):15-30. PubMed ID: 23160939
    [Abstract] [Full Text] [Related]

  • 15. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA, Johnsrud M, Hodgkins P, Sasané R, Crismon ML.
    Clin Ther; 2012 Apr 28; 34(4):944-956.e4. PubMed ID: 22444786
    [Abstract] [Full Text] [Related]

  • 16. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
    Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson TM, Xie J, Erder MH, Dammerman RS, Robertson B, Wu EQ.
    Am J Manag Care; 2014 Sep 28; 20(9):711-21. PubMed ID: 25365746
    [Abstract] [Full Text] [Related]

  • 17. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC, Khoza S, Oladapo A.
    Curr Med Res Opin; 2011 Sep 28; 27 Suppl 2():13-22. PubMed ID: 21973228
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular events and death in children exposed and unexposed to ADHD agents.
    Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S.
    Pediatrics; 2011 Jun 28; 127(6):1102-10. PubMed ID: 21576311
    [Abstract] [Full Text] [Related]

  • 19. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
    Winterstein AG, Soria-Saucedo R, Gerhard T, Correll CU, Olfson M.
    J Clin Psychiatry; 2017 Jul 28; 78(7):e744-e781. PubMed ID: 28686819
    [Abstract] [Full Text] [Related]

  • 20. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS, Wang S, Crystal S, Olfson M.
    JAMA Netw Open; 2019 Jul 03; 2(7):e197850. PubMed ID: 31348506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.